The researchers have found a new therapy to treat the common sexual problem of erectile dysfunction. It is a therapy, known as Low-intensity extracorporeal shock wave therapy (Li-ESWT). It is safe and effective in healing every stage (mild-moderate) of erectile dysfunction, which is suggested in new data. This therapeutic success has been conducted on the young patient, who is having a short duration of male impotence sexual problem, which is not associated with comorbidities the one of the greatest MD of Alexandra University in Alexandria, Egypt, and colleagues at the urology.

The great person in MD of Alexandra University and his team members have studied around 425 patients who are going through with vasculogenic Erectile Dysfunction. Those on whom the experiment was conducted with Li-ESWT with the PiezoWave2 device have assessed that erectile dysfunction using the sexual health inventory for men (SHIM) score. It includes a total of five questions where each is having the possibility to respond to scores from 1-5. The one who scores five questions is added to arrive at a total score of 25 (highest attainable score). This procedure indicates that the higher the score, the effective the male impotence issue functions. The researchers have found out that the defined successful treatment is having six months of the therapy only to one who scores 22 to 25 SHIM resulting in having no signs of having male impotence.

It is concluded that the shorter the duration of erectile dysfunction with the younger age, the lower the pre-treatment SIM score. “Also, avoiding smoking, hypertension, diabetes, and obesity are extensively connected with the odds of Li-ESWT success.” said the MD of Alexandra University and the colleagues of Urology. The successful result is found when the treatment is taken until 30 months with having a proper follow up without using the PD5 inhibitors, according to the investigators.

The study has bought a limitation, to have a lack of control group in receiving the sham treatment. It is noticed by the investigators and founded that many patients have got the original response to the treatment that is placed with PDE5 inhibitors where they have not differentiated the response of medication before Li-ESWT.